Key result
A sensitive and fast UHPLC-MS/MS method was developed for simultaneous quantitation of clopidogrel and its metabolites in human plasma, achieving an LLOQ of 0.05 ng/ml.
This study presents a highly sensitive and fast UHPLC-MS/MS method for quantifying clopidogrel and its active metabolite H4 in human plasma, which could facilitate pharmacokinetic studies.
Answers are grounded in this paper and cite their sources.
May facilitate clopidogrel pharmacokinetic studies; leaves open clinical adoption pending validation.
BACKGROUND: Quantitation of CAM H4 in biological matrix has been a challenge due to low concentrations, instability and the existence of four CAM diastereomers. Historically, either inactive clopidogrel acid or CAM diastereomers without separation were measured for exposure and PK parameters. RESULTS: This study presents a sensitive and fast UHPLC-MS/MS method for simultaneous quantitation of clopidogrel, clopidogrel acid and active metabolite H4 in human plasma. The method demonstrated the separation of H4 from other isomers and yet retained clopidogrel acid. Matrix stabilities, accuracy and precision, recovery and matrix effect were evaluated during development. CONCLUSION: With LLOQ of 0.05 ng/ml for clopidogrel and H4, and 5.5 min LC gradient, it is the most sensitive and fastest method to our knowledge.
No takes yet. Share an insight, caveat, or question.
Hua et al. (2015) studied this question. UHPLC-MS/MS method was evaluated on Simultaneous quantitation of clopidogrel, clopidogrel acid and active metabolite H4. A sensitive and fast UHPLC-MS/MS method was developed for simultaneous quantitation of clopidogrel and its metabolites in human plasma, achieving an LLOQ of 0.05 ng/ml.
Synapse has enriched 10 related papers. Consider them for comparative context: